FRELICK JEFF (Chief Executive Officer) purchased 123.3% of their position (9.50K shares) of BONE BIOLOGICS CORP on the open market
Open‑market purchase worth $6.5K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 9/12/2023ACC: 0001493152-23-032321
Officer· Chief Executive Officer
Since Jan 2022
+9.50K
Net shares
Net buyer
$6.5K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
9.50K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+9.50K
Price / share
$0.69
Trade value
$6.53K
% of position
123.3%
9/11/2023
7.70K→17.20K
Total
Net shares
+9.50K
Net value
$6.53K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/11/2023 | P · Purchase | +9.50K | $0.69 | $6.53K | 123.3% | 7.70K | 17.20K |
| Total | +9.50K | $6.53K | ||||||
Derivative Transactions0
No derivative transactions reported